Comparison of chest radiological findings between coronavirus disease 2019 pneumonia and anti-melanoma differentiation-associated gene 5 antibody- positive interstitial pneumonia by artificial intelligence-based quantitative computed tomography image analysis
Authors:
Preprint
- 7 December 2023
- preprint
- Published by Springer Nature in Research Square
Abstract
Background Coronavirus disease 2019 (COVID-19) pneumonia and anti-melanoma differentiation-associated gene 5 antibody-positive interstitial pneumonia (MDA5-IP) share many similarities; however, the treatment and management of the two diseases are different. In the early stages of developing a treatment plan, it is crucial to distinguish between the two diseases. This study was conducted to compare the radiological findings between COVID-19 pneumonia and MDA5-IP. Methods We recruited patients with COVID-19 pneumonia between January and June 2020. The control group comprised patients with MDA5-IP admitted between April 2013 and December 2019. Patients with thin-slice computed tomography (CT) images within 2 days of admission were enrolled. The CT images were analyzed using an artificial intelligence-based quantitative CT software program. Radiological findings were classified as faint ground-glass opacity (GGO), GGO, reticulation, consolidation, honeycombing, nodules, hyperlucency, or interlobular septum. The volumes of these radiological findings were compared between the two groups. A classification and regression tree algorithm was used to develop a prediction model to stratify the risk of COVID-19 pneumonia. Results We enrolled 72 and 15 patients in the COVID-19 pneumonia and MDA5-IP group, respectively. Faint GGO and consolidations were observed more extensively in patients with MDA5-IP. The prediction model was developed at cut-off values of faint GGO, < 30%; GGO, ≥ 10%, and consolidation < 1%. This prediction model contributed to changing post-test probability in 26% of cases. Conclusion The COVID-19 group showed fewer faint GGO and consolidation volumes than the MDA5-IP group. We developed a predictive model to stratify the risk of COVID-19 pneumonia.Keywords
All Related Versions
This publication has 22 references indexed in Scilit:
- Coronavirus Disease 2019 (COVID-19): A Systematic Review of Imaging Findings in 919 PatientsAmerican Journal of Roentgenology, 2020
- Clinical Features and Chest CT Manifestations of Coronavirus Disease 2019 (COVID-19) in a Single-Center Study in Shanghai, ChinaAmerican Journal of Roentgenology, 2020
- Time Course of Lung Changes at Chest CT during Recovery from Coronavirus Disease 2019 (COVID-19)Radiology, 2020
- A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19New England Journal of Medicine, 2020
- Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive studyThe Lancet Infectious Diseases, 2020
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, ChinaThe Lancet, 2020
- Multicenter Prospective Study of the Efficacy and Safety of Combined Immunosuppressive Therapy With High‐Dose Glucocorticoid, Tacrolimus, and Cyclophosphamide in Interstitial Lung Diseases Accompanied by Anti–Melanoma Differentiation–Associated Gene 5–Positive DermatomyositisArthritis & Rheumatology, 2019
- The diagnostic utility of anti-melanoma differentiation-associated gene 5 antibody testing for predicting the prognosis of Japanese patients with DMRheumatology, 2012
- HRCT features of interstitial lung disease in dermatomyositis with anti-CADM-140 antibodyRespiratory Medicine, 2011
- Autoantibodies to a 140‐kd polypeptide, CADM‐140, in Japanese patients with clinically amyopathic dermatomyositisArthritis & Rheumatism, 2005